Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Seattle Genetics wins FDA priority review for oral HER2 drug

If approved will compete with AZ/Daiichi Sankyo's Enhertu

AstraZeneca AZ

AZ revenues rise, but it says coronavirus could hit 2020

Product sales up 12% to $23.57bn for the full-year

- PMLiVE

FDA begins speedy review of BMS’ CAR-T liso-cel

Agency sets target action date of 17 August for final decision

- PMLiVE

It’s Teenage Kicks for Lucid Group

Lucid has been celebrating its 13th birthday this week. From New York to Singapore, Dubai, Macclesfield and London, teams have been gathering to celebrate the start of its teenage years.The...

Lucid Group Communications Limited

- PMLiVE

20 for 2020 – Five pharma companies to watch

As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020

EISAI

Eisai agrees to pull obesity drug Belviq after safety alert

Weight-loss drug linked to increased risk of cancer

- PMLiVE

China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir

Raises concerns over patent exclusivity in the country

- PMLiVE

FDA sets Q3 decision date for NS Pharma’s DMD drug

If approved it will become second-to-market after Sarepta

- PMLiVE

McCann Health launches creative careers programme in London and New York

The IGNITE programme aims to kick start creative careers

- PMLiVE

Revenue growth at Ipsen numbs pain of palovarotene calamity

French speciality drugmaker posted €2.58bn sales for the full-year

- PMLiVE

M Booth Health appoints Karen Strauss to lead strategy and innovation

Strauss joins with expertise and experience gained at Ketchum

- PMLiVE

Merck chases Roche with triple-negative breast cancer data for Keytruda

Data demonstrated a delay in disease progression or death

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links